Literature DB >> 12835966

Covered stents in transjugular portosystemic shunt: healing response to non-porous ePTFE covered stent grafts with and without intraluminal irradiation.

Klaus A Hausegger1, Horst Portugaller, Nicolas P Macri, Josef Tauss, Peter Schedlbauer, Johannes Deutschmann, Georg Stücklschweiger, Heidi Stranzl.   

Abstract

The aim of this study was to evaluate the healing response to a new commercially available ePTFE-covered stent graft used to create transjugular intrahepatic portosystemic shunts (TIPS) in an animal model with and without intraluminal irradiation. The study was designed for ten domestic normotensive pigs. The TIPS was created using a ePTFE-covered stent graft (Viatorr, Gore, Flagstaff, Ariz.). Five animals were scheduled for intraluminal irradiation with iridium 192 immediately after TIPS creation with a dosage of 18 Gy. Shunt venograms were performed every 2 weeks. Animals from the irradiated and non-irradiated group were killed at 2-week intervals. Maximum follow-up was planned for 8 weeks in each group, with two animals in reserve. Gross specimen evaluation and histological examination, including scanning electron microscopy, was performed. Two animals died from interventional complications. In the irradiation group, one shunt occlusion and one stenosis occurred after 2 weeks. The stenosis regressed until the end of the 8-week follow-up period and probably was caused by a resolving thrombus. In the non-irradiated group, no shunt dysfunction was observed. One animal died early due to encephalopathy. Histology revealed an increased inflammatory reaction in the irradiation group, a lesser degree of incorporation of the stent graft, and a lesser degree of endothelialization of the inner surface compared with the non-irradiated group. No significant foreign body reaction was found at any time in any of the animals. The Viatorr stent graft was well tolerated in the pig model. Intraluminal irradiation seemed to have an adverse effect on the healing response. The TIPS patency was prolonged in both the irradiated and non-irradiated group compared with data from the literature; however, seemingly better results were observed in the non-irradiated group.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12835966     DOI: 10.1007/s00330-002-1690-x

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  21 in total

1.  Transjugular intrahepatic portosystemic shunt with silicone-covered Wallstents: results in a swine model.

Authors:  H Tanihata; R R Saxon; Y Kubota; D Pavcnik; B T Uchida; J Rosch; F S Keller; R Yamada; M Sato
Journal:  Radiology       Date:  1997-10       Impact factor: 11.105

2.  Histopathologic analysis of transjugular intrahepatic portosystemic shunts.

Authors:  H Ducoin; J El-Khoury; H Rousseau; K Barange; J M Peron; M T Pierragi; J L Rumeau; J P Pascal; J P Vinel; F Joffre
Journal:  Hepatology       Date:  1997-05       Impact factor: 17.425

3.  192IR endovascular brachytherapy for avoidance of intimal hyperplasia after percutaneous transluminal angioplasty and stent implantation in peripheral vessels: 6 years of experience.

Authors:  B Schopohl; D Leirmann; L J Pohlit; R Heyd; G Strassmann; R Bauersachs; D Schulte-Huermann; C G Rahl; K H Manegold; J Kollath; H D Bottcher
Journal:  Int J Radiat Oncol Biol Phys       Date:  1996-11-01       Impact factor: 7.038

4.  Transjugular intrahepatic portosystemic shunts formed with polyethylene terephthalate-covered stents: experimental evaluation in pigs.

Authors:  Z J Haskal; L H Brennecke
Journal:  Radiology       Date:  1999-12       Impact factor: 11.105

5.  Improved patency of transjugular intrahepatic portosystemic shunts in humans: creation and revision with PTFE stent-grafts.

Authors:  Z J Haskal
Journal:  Radiology       Date:  1999-12       Impact factor: 11.105

6.  Development of stenoses in transjugular intrahepatic portosystemic shunts.

Authors:  G K Nazarian; H Ferral; W R Castañeda-Zúñiga; H Bjarnason; M C Foshager; J M Rank; C A Anderson; G J Rengel; M E Herman; D W Hunter
Journal:  Radiology       Date:  1994-07       Impact factor: 11.105

7.  Creation of transjugular intrahepatic portosystemic shunts with the wallstent endoprosthesis: results in 100 patients.

Authors:  J M LaBerge; E J Ring; R L Gordon; J R Lake; M M Doherty; K A Somberg; J P Roberts; N L Ascher
Journal:  Radiology       Date:  1993-05       Impact factor: 11.105

8.  PTFE-encapsulated endovascular stent-graft for transjugular intrahepatic portosystemic shunts: experimental evaluation.

Authors:  Z J Haskal; A Davis; A McAllister; E E Furth
Journal:  Radiology       Date:  1997-12       Impact factor: 11.105

9.  Improved transjugular intrahepatic portosystemic shunt patency with PTFE-covered stent-grafts: experimental results in swine.

Authors:  K Nishimine; R R Saxon; K Kichikawa; J Mendel-Hartvig; H A Timmermans; H J Shim; B T Uchida; R E Barton; F S Keller; J Rösch
Journal:  Radiology       Date:  1995-08       Impact factor: 11.105

10.  Multicenter investigation of the role of transjugular intrahepatic portosystemic shunt in management of portal hypertension.

Authors:  D M Coldwell; E J Ring; C R Rees; G Zemel; M D Darcy; Z J Haskal; M A McKusick; A J Greenfield
Journal:  Radiology       Date:  1995-08       Impact factor: 11.105

View more
  1 in total

1.  Early and long-term clinical and radiological follow-up results of expanded-polytetrafluoroethylene-covered stent-grafts for transjugular intrahepatic portosystemic shunt procedures.

Authors:  Geert Maleux; Frederik Nevens; Alexander Wilmer; Sam Heye; Chris Verslype; Maria Thijs; Guy Wilms
Journal:  Eur Radiol       Date:  2004-06-25       Impact factor: 5.315

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.